Global opportunities for commercial interaction and commercial positioned collaborations that overlap in ageing

Prof Mark  Birch-Machin, Associate Dean of Business Development, Professor of Molecular Dermatology, Faculty Ambassador for the UK National Innovation Centre for Ageing, Faculty of Medical Sciences, Newcastle University, UK and Co-Director of PB Biosciences Ltd, United Kingdom

Global opportunities for commercial interaction and commercial positioned collaborations in the ageing sector

• 4Gen Ventures: Becoming the leading ‘age-tech’ investor
• Understanding commercial opportunities in ageing 
• Independent horizon scanning to pick up global ageing trends
• Leveraging on theories of ageing

ABOUT SPEAKER

He previously
worked at Universities in Oregon, Paris and Toronto. He is a member of the
Editorial Board of several international dermatology journals, and
national/international advisory boards (including cosmetic companies) and grant
committees for skin research and UK cosmetic regulation.

His research
group focuses on the response of human skin to the environment, particularly
within the context of skin ageing and has been funded over the last 30 years by
UK research councils, charities, UK government as well as global companies. He
has played a pivotal role in pioneering the use of mitochondrial DNA as a
biomarker of sun damage in skin. He has an interest in understanding the role
of mitochondria in UV and environmental-induced oxidative stress, skin cancer
and the relationship between oxidative stress, nutritional status, pigmentation
and skin aging as well as the science and use of sunscreens. He has published
extensively including 3 different Nature journals.

He has co-founded
two spin out companies (Canadian and UK) and is also a co-inventor on multiple
patents including the invention of a dermatology product that sold in over a
1,000 stores in Canada. He has a long established
track record of working with international media for more than 20 years.